These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33613291)

  • 41. Exploring the Therapeutic Mechanism of
    Hou J; Chen W; Lu H; Zhao H; Gao S; Liu W; Dong X; Guo Z
    Front Pharmacol; 2018; 9():620. PubMed ID: 29950996
    [No Abstract]   [Full Text] [Related]  

  • 42. A Network Pharmacology Approach to Investigate the Anticancer Mechanism and Potential Active Ingredients of
    Zhang Q; Liu J; Li R; Zhao R; Zhang M; Wei S; Ran D; Jin W; Wu C
    Front Pharmacol; 2020; 11():528308. PubMed ID: 33250766
    [No Abstract]   [Full Text] [Related]  

  • 43. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 45. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational Prediction of Antiangiogenesis Synergistic Mechanisms of Total Saponins of
    Guo X; Ji J; Jose Kumar Sreena GS; Hou X; Luo Y; Fu X; Mei Z; Feng Z
    Front Pharmacol; 2020; 11():566129. PubMed ID: 33324204
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of Key Genes and Pathways in Female Lung Cancer Patients Who Never Smoked by a Bioinformatics Analysis.
    Shi K; Li N; Yang M; Li W
    J Cancer; 2019; 10(1):51-60. PubMed ID: 30662525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-93-5p may be an important oncogene in prostate cancer by bioinformatics analysis.
    Yang Y; Jia B; Zhao X; Wang Y; Ye W
    J Cell Biochem; 2019 Jun; 120(6):10463-10483. PubMed ID: 30582208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploration of estrogen receptor-associated hub genes and potential molecular mechanisms in non-smoking females with lung adenocarcinoma using integrated bioinformatics analysis.
    Wang H; Zhang Z; Xu K; Wei S; Li L; Wang L
    Oncol Lett; 2019 Nov; 18(5):4605-4612. PubMed ID: 31611968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of differential expression profiles reveals potential biomarkers associated with the cell cycle and regulated by p53 in human small cell lung cancer.
    Ni Z; Wang X; Zhang T; Li L; Li J
    Exp Ther Med; 2018 Apr; 15(4):3273-3282. PubMed ID: 29545845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of potential cancer-related molecular targets of North African plants constituents using network pharmacology-based analysis.
    Shawky E
    J Ethnopharmacol; 2019 Jun; 238():111826. PubMed ID: 30910579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Network analysis of differentially expressed genes reveals key genes in small cell lung cancer.
    Tantai JC; Pan XF; Zhao H
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1364-72. PubMed ID: 25967710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
    Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
    Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

  • 58. Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer.
    Zhang M; Gao CE; Li WH; Yang Y; Chang L; Dong J; Ren YX; Chen D
    Oncol Lett; 2017 Apr; 13(4):2770-2776. PubMed ID: 28454465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.